Disease | ischemic stroke |
Phenotype | C0022658|renal disease |
Sentences | 3 |
PubMedID- 26073213 | Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary. |
PubMedID- 25449515 | Anti-platelet or anti-coagulant agent for the prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation--a nation-wide database analyses. |
PubMedID- 24597578 | Conclusions: antiplatelet therapy, especially aspirin, still offers safe and effective treatment for ischemic stroke prevention in patients with end-stage renal disease undergoing dialysis. |
Page: 1